Progression from ductal carcinoma in situ to invasive breast cancer: revisited

scientific article published on 12 July 2013

Progression from ductal carcinoma in situ to invasive breast cancer: revisited is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MOLONC.2013.07.005
P932PMC publication ID5528459
P698PubMed publication ID23890733
P5875ResearchGate publication ID253332848

P50authorJorge Reis-FilhoQ23892845
Britta WeigeltQ71780641
Tari A KingQ91150434
Rita SakrQ114337809
P2093author name stringJames Hicks
Charlotte K Y Ng
Catherine F Cowell
P2860cites workAn intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situQ22000769
An integrated encyclopedia of DNA elements in the human genomeQ22122150
Matrix crosslinking forces tumor progression by enhancing integrin signalingQ24646370
The microenvironment in breast cancer progression: biology and implications for treatmentQ26851314
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingQ27860948
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomesQ28270358
Genome remodelling in a basal-like breast cancer metastasis and xenograftQ28395637
Tumour evolution inferred by single-cell sequencingQ28646966
Inferring tumor progression from genomic heterogeneityQ28749457
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane culturesQ29547700
The life history of 21 breast cancersQ29614642
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolutionQ29619477
The clonal and mutational evolution spectrum of primary triple-negative breast cancersQ29619914
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridizationQ30673310
Molecular characterization of the tumor microenvironment in breast cancerQ31095898
Molecular markers in ductal carcinoma in situ of the breast.Q31135997
Gene expression profiles of human breast cancer progressionQ33186821
Gene expression profiling of the tumor microenvironment during breast cancer progressionQ33404889
Myoepithelial cells: their origin and function in breast morphogenesis and neoplasiaQ33557658
Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.Q33944570
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepitheliaQ34088976
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2.Q34206453
Absolute quantification of somatic DNA alterations in human cancerQ34271693
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesQ34327021
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.Q34577467
Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.Q34694010
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.Q35182627
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumoursQ36116099
Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breastQ36300973
Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.Q36355592
Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cellQ36415307
Do myoepithelial cells hold the key for breast tumor progression?Q36522966
Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progressionQ36522971
Evolution and impact of subclonal mutations in chronic lymphocytic leukemiaQ36619124
Molecular cytogenetic analysis of 11 new breast cancer cell linesQ36619975
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breastQ36843620
FGFR1 is amplified during the progression of in situ to invasive breast carcinomaQ36924421
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancerQ36955125
Regulation of in situ to invasive breast carcinoma transitionQ36995611
Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breastQ37097204
No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomasQ37098932
A human breast cell model of preinvasive to invasive transition.Q37143783
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selectionQ37155717
LOXL2-mediated matrix remodeling in metastasis and mammary gland involutionQ37346579
Reconstruction of functionally normal and malignant human breast tissues in miceQ37415657
Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancerQ37507568
Breast cancer precursors revisited: molecular features and progression pathwaysQ37760539
Cancer genome-sequencing study designQ38099732
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic lociQ38472116
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transitionQ39513776
Distinct epigenetic changes in the stromal cells of breast cancersQ39722911
Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane cultureQ39872010
The pathology of invasive breast cancerA Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4)Q39967188
Intraductal carcinoma of the breast: Follow-up after biopsy onlyQ40127804
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progressionQ40291730
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancerQ41130424
Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancerQ42491858
Identification of a basal-like subtype of breast ductal carcinoma in situQ42507010
Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breastQ42513085
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breastQ42526325
Tumor progression in four mammary epithelial cell lines derived from the same patientQ42809631
Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patternsQ42814075
Gene amplification in ductal carcinoma in situ of the breastQ45723421
The human myoepithelial cell is a natural tumor suppressorQ46183897
MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ.Q52832877
Intratumor heterogeneity: seeing the wood for the trees.Q53097757
Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.Q53262835
Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma.Q53405516
Promoter CpG island hypermethylation during breast cancer progression.Q53449089
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.Q53568961
HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.Q53597732
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.Q54757490
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.Q55223470
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinomaQ59573887
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progressionQ63372138
On the origin and progression of ductal carcinoma in the human breastQ69998182
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsyQ71079558
Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breastQ71767613
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypesQ73341667
Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric studyQ73680610
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathwaysQ77976506
The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breastQ78656284
Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridizationQ79661456
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-upQ81731306
Genetic heterogeneity and cancer drug resistanceQ83791245
P433issue5
P921main subjectductal carcinomaQ5311598
breast cancerQ128581
P304page(s)859-869
P577publication date2013-07-12
P1433published inMolecular OncologyQ2190736
P1476titleProgression from ductal carcinoma in situ to invasive breast cancer: revisited
P478volume7

Reverse relations

cites work (P2860)
Q92260652A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
Q92257886APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer
Q90370810ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition
Q28083103Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast
Q38612319Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice
Q38785162Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Q38764251Catalog of genetic progression of human cancers: breast cancer
Q38388286Caveolae and signalling in cancer
Q36087440Cellular senescence and autophagy of myoepithelial cells are involved in the progression of in situ areas of carcinoma ex-pleomorphic adenoma to invasive carcinoma. An in vitro model
Q92596378Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
Q97538221Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
Q96642228Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
Q41641225Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
Q38333149Current management of lesions associated with an increased risk of breast cancer
Q90467694Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers
Q58595841Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing
Q90184743Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment
Q38696796Ductal carcinoma in situ - update on risk assessment and management
Q91723932Ductal carcinoma in situ: to treat or not to treat, that is the question
Q27025321Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment
Q92480700Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer
Q63633881Ectopic expression of PLC‐β2 in non‐invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR‐146a
Q47821353Epithelial-mesenchymal transition inducer Snail1 and invasive potential of intraductal breast cancer.
Q58693482Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats
Q39296522Evolution of Premalignant Disease.
Q38746332Family history and risk of breast cancer: an analysis accounting for family structure
Q39056693Force-dependent breaching of the basement membrane
Q39012815Genome evolution in ductal carcinoma in situ: invasion of the clones
Q89267498Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma
Q55554673Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.
Q37219845Glucose Uptake and Intracellular pH in a Mouse Model of Ductal Carcinoma In situ (DCIS) Suggests Metabolic Heterogeneity
Q47169465Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells.
Q38757831Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer
Q52894184Histogram analysis of volume-based apparent diffusion coefficient in breast cancer.
Q36902060How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
Q90220716Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS)
Q94471981Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians
Q39013710Identifying progression predictors of breast ductal carcinoma in situ.
Q87070703Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast
Q92001842Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Q90593569In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ
Q56999072Integrated analysis of dysregulated lncRNA expression in breast cancer cell identified by RNA-seq study
Q33618236Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells
Q57159647Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence
Q55251624Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.
Q91795301MicroRNA Profiling of Salivary Duct Carcinoma Versus Her2/Neu Overexpressing Breast Carcinoma Identify miR-10a as a Putative Breast Related Oncogene
Q48221533Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology
Q34576614Molecular Markers as Prognostic Factors in DCIS and Small Invasive Breast Cancers
Q47200971Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing
Q92624732Nanoemulsions Enhance in vitro Transpapillary Diffusion of Model Fluorescent Dye Nile Red
Q35693355Non-coding RNAs derived from an alternatively spliced REST transcript (REST-003) regulate breast cancer invasiveness
Q98178015Novel role for the Golgi membrane protein TMEM165 in control of migration and invasion for breast carcinoma
Q49988885On the trail of invasive cells in breast cancer
Q33587930PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma
Q61808697Parity Differently Affects the Breast Cancer Specific Survival from Ductal Carcinoma In Situ to Invasive Cancer: A Registry-Based Retrospective Study from Korea
Q29994686Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ
Q38888197Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Q57032491Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
Q59799842Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells
Q36317741Role of multi-mode ultrasound in the diagnosis of level 4 BI-RADS breast lesions and Logistic regression model
Q38261363Sex, eyes, and vision: male/female distinctions in ophthalmic disorders
Q92340124TGF-β1 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer
Q90582974The Importance of Risk-Reducing Prophylactic Mastectomy in Breast Cancer (BRCA) Carriers: A Case Report
Q37705673The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells
Q35660389The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
Q33736524The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells
Q37635620The regulation of tumor suppressor protein, p53, and estrogen receptor (ERα) by resveratrol in breast cancer cells
Q37371138Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model
Q34023603Towards optimal treatment of ductal carcinoma in situ
Q36447987Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
Q90394997Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile
Q38703282Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling
Q26785362Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
Q42653642Vaccines and early breast cancer
Q90710834Whole-Exome Sequencing Analysis of the Progression from Non-Low Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
Q38884681p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer.

Search more.